LATEST NEWS

LJI Research Technician Adam Abawi uses graphic design to capture scientific concepts
Local high school students win top honors in LJI competition
Researchers at LJI and Columbia University uncover exactly how a neutralizing antibody blocks measles virus infection
Researchers at La Jolla Institute for Immunology (LJI) are taking a closer look at how measles virus fuses with cells
Ramirez brings a doctor's perspective to infectious disease research
LJI scientists zero in on T cells that may drive autoimmune disease in human patients
The Weiskopf lab studies how the body battles emerging viruses to prepare for pandemic threats
In this seminar, Dr. Duane Wesemann, MD, Ph.D., of Brigham and Women’s Hospital and Harvard Medical School, presents new research
LJI film makes it to the Golden State Film Festival and Hollywood's historic Chinese Theater
New research may help scientists hunt down solid tumors and better diagnose disease
LA JOLLA, CA—New research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced “breakthrough” infections are especially well armed against future SARS-CoV-2 infections.
Leading immunologist honored for research into the roots of autoimmunity, cancer development, and more